- Eagle Pharmaceuticals ( NASDAQ: EGRX ) is scheduled to announce Q2 earnings results on Tuesday, August 9th, before market open.
- The consensus EPS Estimate is $3.36 (+261.3% Y/Y) and the consensus Revenue Estimate is $116.89M (+142.9% Y/Y).
- Over the last 2 years, EGRX has beaten EPS estimates 50% of the time and has beaten revenue estimates 25% of the time.
- Over the last 3 months, EPS estimates have seen 1 upward revision and 2 downward. Revenue estimates have seen 1 upward revision and 2 downward.
For further details see:
Eagle Pharmaceuticals Q2 2022 Earnings Preview